TREATMENT OUTCOMES OF LACTULOSE THERAPY IN PEDIATRIC FUNCTIONAL CONSTIPATION AT THE THAI BINH PEDIATRIC HOSPITAL

Thị Hải Linh Trịnh , Thị Quỳnh Anh Phí, Thị Việt Hà Nguyễn

Main Article Content

Abstract

Constipation is a common digestive disorder in children, of which functional constipation accounts for 90–95% of cases. Aim: To evaluate the treatment outcomes of functional constipation in children aged < 6 years using a regimen with Lactulose at Thai Binh Pediatric Hospital. Materials and Methods: An interventional study was conducted on 86 children aged 1 to 6 years diagnosed with functional constipation according to the ROME IV criteria, from June 1, 2024, to May 31, 2025. Results: The boy-to-girl ratio was 1.3, and the mean age was 30.2 ± 17.4 months. The recovery rate from constipation after 1, 2 and 3 month of treatment was 65%, 70.1% and 79.1%, respectively. The rates of clinical symptoms such as straining, anal pain during defecation, anal fissures, fecal soiling, stool withholding posture, and passage of hard stools significantly decreased after the first month of treatment (p < 0.05). After 3 months, no children had stool type 1 according to the Bristol Stool Scale. The average number of bowel movements per week improved from 1.7 ± 0.5 times/week to 3.9 ± 1.7 times after 1 month, 5.0 ± 1.7 times after 2 months, and 5.7 ± 1.7 times after 3 months of treatment (p < 0.001). Adverse effects were mainly gastrointestinal and mostly self-limiting. Conclusion: The Lactulose regimen with an initial dose of 1 ml/kg/day combined with dietary and behavioral counseling provided high clinical efficacy, improving symptoms, bowel movement frequency, stool consistency, lifestyle habits, and safety.

Article Details

References

. (2006). Epidemiologyof childhood constipation: a systematic review. The American Journal of Gastroenterology. 101(10),2401-2409.
2. Tabbers MM, Di Lorenzo C, Berger MY, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition; North American Society for Pediatric Gastroenterology. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. The Journal of Pediatric Gastroenterology and Nutrition. 2014; 58(2): 258–274.
3. Bongers MEJ, van Wijk MP, Reitsma JB, et al. Long-term prognosisfor childhood constipation: clinical outcomes in adulthood. Pediatrics. 2010; 126(1):156-162.
4. Đỗ Thị Minh Phương, Nguyễn Thị Việt Hà. Đánh giá hiệu quả điều trị táo bón mạn tính chức năng ở trẻ em: thử nghiệm lâm sàng mở, ngẫu nhiên có đối chứng. Tạp chí Y học thực hành. 2017; 1043(5):127–129.
5. Đào Thị Trân Huyền, Nguyễn Thị Việt Hà. Hiệu quả của hai phác đồ sử dụng polyethylene glycol 3350 và lactulose trong điều trị táo bón mạn tính chức năng ở trẻ em dưới 6 tuổi. Tạp chí Nghiên cứu Y học. 2021; 145(9), 119-128.
6. Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2016;150(6): 1456-68.
7. Candy DCA, Edwards D, Geraint M. Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy. The Journal of Pediatric Gastroenterology and Nutrition. 2006;43:65–70.
8. Jarzebicka D, Sieczkowska-Golub J,Kierkus J, et al. PEG 3350 versus Lactulose for treatment of functional constipation in children: Randomized Study. The Journal of Pediatric Gastroenterology and Nutrition. 2019; 68 (3):318-324.